Climb Bio, Inc. (CLYM) Insider Ownership

Over the 90-day window ending January 09, 2026, Climb Bio's three dominant insider ownership positions are held by TenPercentOwner Eti Llc Ai (5.01Mn shares), Director Capital Management, L.P. Ra (3.40Mn shares), Director Stephen Basil Thomas (304.66K shares).

• The shareholding composition of Climb Bio (CLYM) reflects broad market participation, with institutional funds owning 65.67%, executive insider stakes representing 12.20%, with public and others accounting for 22.12%.
• Current insider holdings at Climb Bio account for 12.20% of total shares outstanding as of January 09, 2026, totaling roughly 8.28Mn shares from the company's 67.83Mn share base.
• Throughout the 90-day span concluding January 09, 2026, Climb Bio's insider stake increased 1.23%, as collective insider positions growing from 8.18Mn shares to 8.28Mn shares.
• Over the past 90 days through January 09, 2026, Director Capital Management, L.P. Ra demonstrated the strongest insider purchase conviction at Climb Bio, adding 321.67K shares to their position.
• As of January 09, 2026, Director Capital Management, L.P. Ra executed the most significant insider divestiture at Climb Bio, disposing of 20.44Mn shares over the last 90-day period.